Gene · 406993
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-Scale Production of Secretome From Human Dental Pulp Stem Cells for Articular Cartilage Regeneration. | Stem Cells Int | 2026 | 42472184 | PubTator, text mining | PubMed |
| Screening and identification of the ncRNA-mRNA regulatory network associated with DNA methylation in goose embryonic myoblasts. | BMC Genomics | 2026 | 42316346 | PubTator, text mining | PubMed |
| Mesoporous silica nanoparticle-mediated delivery of a synergistic 5-miRNA combination inhibits HSV-2 infection. | Sci Rep | 2026 | 42265164 | PubTator, text mining | PubMed |
| Network-based analysis reveals potential microRNA regulation of oncogenic pathways in SOX10-depleted uveal melanoma. | Cell Mol Life Sci | 2026 | 42120529 | PubTator, text mining | PubMed |
| Retraction: Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM. | Oncotarget | 2026 | 42030571 | PubTator, text mining | PubMed |
| Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. | Oncotarget | 2026 | 42030541 | PubTator, text mining | PubMed |
| Evolution in metazoans of the TRPM channel family involves multiple gains and losses of genes and domains. | Mol Biol Evol | 2026 | 41968578 | PubTator, text mining | PubMed |
| Anticarcinogenic effects of miR-199a-loaded gold nanoparticles on hepatocellular carcinoma: in vitro study. | Sci Rep | 2026 | 41927705 | PubTator, text mining | PubMed |
| Long non-coding RNA PSMB8-AS1 as a potential biomarker for postoperative recurrence in patients with Fuhrman grades 1-3 clear cell renal cell carcinoma. | PLoS One | 2026 | 41811824 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
| Molecular and Clinicopathological Biomarkers Predicting Brain Metastasis in Triple-Negative Breast Cancer: A Systematic Review. | Int J Mol Sci | 2026 | 41752044 | PubTator, text mining | PubMed |
| Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. | Curr Issues Mol Biol | 2026 | 41751395 | PubTator, text mining | PubMed |
| The Stiff Side of Cancer: How Matrix Mechanics Rewrites Non-Coding RNA Expression Programs. | Noncoding RNA | 2026 | 41745140 | PubTator, text mining | PubMed |
| Absolute quantification of microRNA miR-875-5p in temporal artery biopsies and its biomarker potential for giant cell arteritis. | Front Immunol | 2026 | 41743717 | PubTator, text mining | PubMed |
| MicroRNA‑microbiome cross‑kingdom networks drive inflammatory bowel disease through dynamic regulatory ecosystems (Review). | Int J Mol Med | 2026 | 41614418 | PubTator, text mining | PubMed |
| Exploring extracellular vesicle MicroRNAs in Usher syndrome type 1B: Tear-Derived EVs as potential indicators of retinal health. | Cell Mol Life Sci | 2026 | 41528484 | PubTator, text mining | PubMed |
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
| Acupuncture alleviates the progression of knee osteoarthritis by inhibiting X-inactive specific transcript-mediated activation of the mechanosensitive ion channel Piezo1 signaling. | Nagoya J Med Sci | 2025 | 41550191 | PubTator, text mining | PubMed |
| The Mechanisms of Lead Toxicity in Living Organisms. | J Xenobiot | 2025 | 40981357 | PubTator, text mining | PubMed |
| The Multifaceted Role of miR-211 in Health and Disease. | Biomolecules | 2025 | 40867554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406993/papers